2-(4-Hexylthiophen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 100mg

1-(2-(Difluoromethoxy)-4-fluorophenyl)ethan-1-ol, 100mg

2-(3-(Pyridin-2-yl)-1,2,4-oxadiazol-5-yl)aniline, 98%, 250mg

(-)-Dibenzoyl-L-tartaric Acid Monohydrate>98.0%(T)500g

3-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 97%, 1g

4-(Chloromethyl)benzoic acid, 95.0%, 500g

(6R,8aS)-6-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)hexahydroindolizin-3(2H)-one, 96%, 100mg

H-D-Dap(N3).HCl, 98.0%, 250mg

Tetrazine-Ph-acid, 100mg

4-Chloromethyl-benzoic acid tert-butyl ester, 95.0%, 250mg

2-(2-((tert-Butoxycarbonyl)amino)-N-methylacetamido)acetic acid, 97%, 250mg

2,3,4,5-Tetrahydro-1H-benzo[4,5]imidazo[1,2-d][1,4]diazepine, 95.0%, 250mg

tert-butyl 3-(hydroxymethyl)-3-methoxyazetidine-1-carboxylate, 5g